explore -WSS

explore

author：leisure time 2025-09-29 01:35:45 - browse：3

Illustration of miniature doctor figurines standing on a stethoscope with a roll of money to the right. — Adobe

Physician staffing firms, flailing in the wake of a federal law banning surprise bills, are demanding extra payment from hospitals to stay afloat. Hospitals, desperate for doctors to staff their facilities, have little choice but to comply.

It’s a big topic of conversation on for-profit hospital earnings calls. Just last week, major hospital chains said those expenses, known as physician subsidies, were up 20% to 40% from last year. And experts say it’s just as bad at not-for-profit hospitals. It’s a complicated problem that’s gotten worse just as contract labor expenses — hospitals’ hallmark problem of the past three years — ease up.

“This is the new contract labor,” said Whit Mayo, senior managing director with Leerink Partners. “This is the new cost issue that the industry is having to deal with.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： WHO recommends second malaria vaccine

WSS

Medicare innovation center doesn’t save money, experts say

With Roe v Wade overturned, abortion providers work to adapt

As AI regulations shape up, health tech startups beg for clarity

Medicare innovation center doesn’t save money, experts say

CRISPR base editing slashes cholesterol levels in monkeys

Surprise medical billing ban raises prices elsewhere

entertainment

explore

knowledge

At least 13 dead in Texas as scorching temps continue

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

The high cost of giving birth even with insurance

A new drug could help frostbite victims avoid its ravages

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

RSV injection headlines need to be accurate for good uptake

United colonoscopy coverage change 'may cost lives,' doctors say

WATCH: Why do our ears pop?

Duchenne breakthrough therapy leaves behind pioneering families

The biotech scorecard for Q4: 16 stock

hotspot

A new drug could help frostbite victims avoid its ravages

New CMS data security rules will hurt Medicare, Medicaid research

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Lawsuit highlights wrinkle for disputes over surprise medical bills

Setback for rare diseases as Taysha Gene Therapies pulls back

Stop Congress from blocking public access to science

focus

Wikipedia

entertainment

knowledge